Patients with MASLD Exhibit In Vivo Changes in Hepatic Response to Oral Fructose Consumption

Following fructose consumption, patients with MASLD exhibited distinct patterns of change in phosphate metabolites, reflecting differences in hepatic metabolic responses. These findings suggest altered hepatic metabolic handling of fructose in MASLD, which may have implications for disease progression.